Calendar Alnylam Pharmaceuticals, Inc.

Equities

ALNY

US02043Q1076

Real-time Estimate Cboe BZX 18:22:01 17/06/2024 BST 5-day change 1st Jan Change
157.4 USD -1.86% Intraday chart for Alnylam Pharmaceuticals, Inc. +2.98% -17.43%

Chart calendar Alnylam Pharmaceuticals, Inc.

0753c0a432d4281cbf4f0f9e44c7.O87-WBea9xtCO3Ft9clGUUuKdhROdTL8S6S_1lFvo1E.ebTGYXajpnENCwQ1uf8jOnPhPEwoGHiGesmN5ykM_ChyjcgSUdyWaQlfQQ~67b43a104e236690a56ae781191a12e3

Upcoming events on Alnylam Pharmaceuticals, Inc.

30/07/2024 Q2 2024 Earnings Release (Projected)
23/10/2024 Q3 2024 Earnings Release (Projected)
05/02/2025 Q4 2024 Earnings Release (Projected)
30/04/2025 Q1 2025 Earnings Release (Projected)

Past events on Alnylam Pharmaceuticals, Inc.

16/05/2024 15:30 Annual General Meeting
02/05/2024 13:30 Q1 2024 Earnings Call
02/05/2024 13:00 Q1 2024 Earnings Release
08/04/2024 00:00 KARDIA-2 Phase 2 Study Results Call
25/03/2024 17:00 Canaccord Genuity Genetic Medicine for Generalists Conference
20/03/2024 14:00 Stifel CNS Day
12/03/2024 14:15 Barclays Global Healthcare Conference
05/03/2024 14:10 TD Cowen Health Care Conference
15/02/2024 13:30 Q4 2023 Earnings Call
15/02/2024 13:00 Q4 2023 Earnings Release
08/01/2024 17:45 JPMorgan Healthcare Conference
13/12/2023 13:30 R&D Day
29/11/2023 14:30 Piper Sandler Healthcare Conference
14/11/2023 14:45 Stifel Healthcare Conference
14/11/2023 10:00 Jefferies London Healthcare Conference
02/11/2023 12:30 Q3 2023 Earnings Call
02/11/2023 12:00 Q3 2023 Earnings Release
24/10/2023 Clinical Trials on Alzheimers Disease Conference
09/10/2023 13:30 ONPATTRO FDA Approval Call
08/10/2023 13:24 Heart Failure Society of America Scientific Meeting - Poster 030

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
220
221
-0.43%
493
476
3.49%
844
823
2.64%
1 037
1 013
2.41%
1 828
1 827
0.1%

1 874

EBITDA
Million USD
Released
Forecast
Spread
-885
-857
-3.28%
-794
-773
-2.74%
-661
-608
-8.65%
-741
-646
-14.71%
0,00
-250
-

-320

EBIT
Million USD
Released
Forecast
Spread
-939
-893
-5.24%
-828
-833
0.51%
-709
-665
-6.58%
-785
-813
3.38%
-282
-275
-2.6%

-372

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-885
-853
-3.84%
-856
-826
-3.59%
-852
-750
-13.68%
-1 127
-1 138
1%
-434
-437
0.72%

-474

Net income
Million USD
Released
Forecast
Spread
-886
-860
-3.08%
-858
-832
-3.22%
-853
-758
-12.46%
-1 131
-1 156
2.16%
-440
-441
0.12%

-448

EPS
USD
Released
Forecast
Spread
-8,11
-7,93
-2.21%
-7,46
-7,18
-3.86%
-7,20
-6,42
-12.12%
-9,30
-9,42
1.32%
-3,52
-3,53
0.29%

-3,53

Announcement Date06/02/2011/02/2110/02/2223/02/2315/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
213
243
-12.17%
225
256
-12.2%
264
292
-9.38%
335
312
7.23%
319
313
2.16%
319
351
-9.08%
751
395
90.22%
440
442
-0.58%
494
427
15.82%

445


460


472


490


513

EBITDA
Million USD
Released
Forecast
Spread
-137
-200
31.43%
-182
-206
11.98%
-247
-118
-110.59%
-174
-185
5.58%
-136
-204
33.36%
-217
-135
-60.01%
227
-134
269.42%

-143

-29,9
-123
75.76%

-115


-79,7


-56,9







EBIT
Million USD
Released
Forecast
Spread
-147
-211
30.37%
-192
-173
-11.02%
-258
-195
-32.42%
-189
-221
14.57%
-150
-180
16.95%
-230
-136
-69.1%
214
-165
229.79%
-116
-114
-2.24%
-43,4
-117
62.87%

-118


-113


-108


-129


-136

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-239
-234
-2.18%
-275
-206
-33.41%
-406
-224
-81.14%
-207
-266
22.17%
-172
-237
27.24%
-274
-162
-68.79%
151
-206
173.12%
-138
-149
7.5%
-63,6
-133
52.26%

-137


-139


-136


-151


-163

Net income
Million USD
Released
Forecast
Spread
-240
-235
-2.25%
-277
-205
-35.27%
-406
-221
-84.03%
-207
-234
11.5%
-174
-217
19.87%
-276
-168
-64.42%
148
-184
180.46%
-138
-157
12.18%
-65,9
-140
53.05%

-139


-137


-123


-152


-165

EPS
USD
Released
Forecast
Spread
-2,00
-1,90
-5.45%
-2,29
-1,64
-39.55%
-3,32
-1,81
-83.85%
-1,68
-1,93
12.92%
-1,40
-1,73
19.14%
-2,21
-1,42
-56.08%
1,18
-1,47
180.25%
-1,10
-1,25
11.8%
-0,52
-1,15
54.62%

-1,11


-1,06


-0,97


-1,05


-1,02

Announcement Date28/04/2228/07/2227/10/2223/02/2304/05/2303/08/2302/11/2315/02/2402/05/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ALNY Stock
  4. Calendar Alnylam Pharmaceuticals, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW